LEADER 04848nam 2200613 a 450 001 9910814240103321 005 20230803032611.0 010 $a1-118-41089-0 010 $a1-118-41087-4 010 $a1-299-15803-X 010 $a1-118-41090-4 035 $a(CKB)3190000000032971 035 $a(EBL)1120569 035 $a(OCoLC)827207737 035 $a(SSID)ssj0000801031 035 $a(PQKBManifestationID)11441277 035 $a(PQKBTitleCode)TC0000801031 035 $a(PQKBWorkID)10772365 035 $a(PQKB)10493923 035 $a(MiAaPQ)EBC1120569 035 $a(Au-PeEL)EBL1120569 035 $a(CaPaEBR)ebr10657953 035 $a(CaONFJC)MIL447053 035 $a(EXLCZ)993190000000032971 100 $a20120306d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTherapeutic advances in thrombosis /$feditors, David J. Moliterno, Steen Dalby Kristensen, Raffaele De Caterina 205 $a2nd ed. 210 $aChichester, West Sussex $cWiley-Blackwell$d2013 215 $a1 online resource (402 p.) 300 $aRev. ed. of: Therapeutic strategies in thrombosis / edited by Steen Dalby Kristensen, Raffaele De Caterina, and David J. Moliterno. 2006. 311 $a1-4051-9625-4 320 $aIncludes bibliographical references and index. 327 $aArterial thrombosis : a brief overview / Lina Badimon and Valentin Fuster -- Aspirin / Carlo Patrono -- Platelet ADP P2Y12 inhibitors - thienopyridines / Joseph D. Foley III and David J. Moliterno -- Platelet ADP P2Y12 Inhibitors - non-thienopyridines / Joseph D. Foley III and David J. Moliterno -- Cilostazol and dipyridamole- more than weak inhibition of platelets / W.G. Eisert -- The inter-relationship of thrombin and platelets - the protease activated receptor-1 (PAR-1) / Matthew E. Wiisanen and David J. Moliterno -- Glycoprotein IIb/IIIa inhibitors / Marco Valgimigli and Elisa Cangiano -- Unfractionated heparin and low-molecular-weight heparin in ischemic heart disease / Marc Cohen, Omar Hassan, and Zafar Iqbal -- Pentasaccharide derivatives / Antonio Gutierrez, Pierluigi Tricoci, and John H.P. Alexander -- Intravenous direct thrombin inhibitors / A. Michael Lincoff -- Vitamin K antagonists / Freek W.A. Verheugt -- Oral direct thrombin inhibitors and oral Xa inhibitors / Steen Husted and Lars Wallentin -- Thrombolytic therapy and concomitant antithrombotic therapies / Peter R. Sinnaeve and Frans J. Van de Werf -- Antithrombotic therapy in STEMI / Kurt Huber, Raffaele De Caterina, Steen Kristensen -- Antithrombotic therapy in non-ST elevation acute coronary syndromes / Georgios J. Vlachojannis ... [et al.] -- Antithrombotic strategies in patients undergoing elective PCI / Sunil V. Rao and E. Magnus Ohman -- Antithrombotic management in patients with prosthetic valves / Eric G. Butchart and Raffaele De Caterina -- Stroke - thrombolysis and antithrombotic therapy / L. Creed Pettigrew and Michael R. Dobbs -- Atrial fibrillation : current and forthcoming antithrombotic therapies / Raffaele De Caterina and Giulia Renda -- Venous thromboembolism : pathophysiology, diagnosis and prophylaxis / M.P. Donadini, W. Ageno, A.G.G. Turpie -- Antithrombotic therapy in venous thrombosis and pulmonary embolism / M. Di Nisio and H.R. Bu?ller -- Prevention and treatment of venous and arterial thrombosis in patients with specific conditions : diabetes, hypercoagulable states, pregnancy and renal insufficiency / Michel Meyer Samama, Jacqueline Conard and Grigoris Gerotziafas -- Genetics of the response to antithrombotic drugs and the need for monitoring / Jean-Philippe Collet, Gilles Montalescot, and Jean-Se?bastien Hulot. 330 $a Managing patients with thrombotic vascular disease is complex and challenging: Ischemic vascular disease remains a complicated interplay of atherosclerosis and thrombosis-even with the evolution in our understanding of the pathobiology of thrombosis. There has been tremendous growth in therapeutic options which are quickly finding their place in daily practice, including a remarkable expansion in the number of intravenous and oral antithrombotic agents and new antiplatelet agents Now more than ever, all cardiologists, hematologists, and specialists in vascular medicine, as well as other p 606 $aThrombosis$xTreatment 606 $aFibrinolytic agents 615 0$aThrombosis$xTreatment. 615 0$aFibrinolytic agents. 676 $a616.1/35 701 $aMoliterno$b David J$0893157 701 $aKristensen$b Steen Dalby$01724628 701 $aCaterina$b Raffaele De$01724629 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910814240103321 996 $aTherapeutic advances in thrombosis$94126875 997 $aUNINA